Experiment 909589

Details

PropertyValue
Pharmacology
Administration routeIV INFUSION
OrganismEmpty organism
CitationANON:. (1990). TAXOL.. 15(1)
Amount utilized
Compound isolated
Disease40 PATIENTS WITH ADVANCED OVARIAN CARCINOMA WERE TREATED IN A PHASE II TRIAL. THERE WAS 1 PATHOLOGICAL CR(8+ MONTHS), 11 CLINICAL PR(1-5+ MONTHS) 5 CLINICAL MR(1-10 MONTHS). DOSE LIMITING TOXICITIES: NEUTROPENIA, LOW GRADE THROMBOCYTOPENIA, ALOPECIA, ARTHRALGIAS/MYALGIAS, CARDIAC TOXICITY AND GRAND MAL SEIZURES.
Dose amountVAR
Number1
Qualitative result.
AnimalHUMAN ADULT
Dose expressionDOSE